JP2019530878A5 - - Google Patents

Download PDF

Info

Publication number
JP2019530878A5
JP2019530878A5 JP2019519961A JP2019519961A JP2019530878A5 JP 2019530878 A5 JP2019530878 A5 JP 2019530878A5 JP 2019519961 A JP2019519961 A JP 2019519961A JP 2019519961 A JP2019519961 A JP 2019519961A JP 2019530878 A5 JP2019530878 A5 JP 2019530878A5
Authority
JP
Japan
Prior art keywords
patient
biomarker
days
label
c11orf74
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019519961A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019530878A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/029468 external-priority patent/WO2018004806A1/en
Publication of JP2019530878A publication Critical patent/JP2019530878A/ja
Publication of JP2019530878A5 publication Critical patent/JP2019530878A5/ja
Priority to JP2022110659A priority Critical patent/JP2022153436A/ja
Pending legal-status Critical Current

Links

JP2019519961A 2016-06-26 2017-04-25 重篤患者における死亡率の予後診断に使用するためのバイオマーカー Pending JP2019530878A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022110659A JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662354789P 2016-06-26 2016-06-26
US62/354,789 2016-06-26
PCT/US2017/029468 WO2018004806A1 (en) 2016-06-26 2017-04-25 Biomarkers for use in prognosis of mortality in critically ill patients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022110659A Division JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Publications (2)

Publication Number Publication Date
JP2019530878A JP2019530878A (ja) 2019-10-24
JP2019530878A5 true JP2019530878A5 (enExample) 2020-06-11

Family

ID=60786346

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019519961A Pending JP2019530878A (ja) 2016-06-26 2017-04-25 重篤患者における死亡率の予後診断に使用するためのバイオマーカー
JP2022110659A Pending JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022110659A Pending JP2022153436A (ja) 2016-06-26 2022-07-08 重篤患者における死亡率の予後診断に使用するためのバイオマーカー

Country Status (7)

Country Link
US (4) US10344332B2 (enExample)
EP (1) EP3475473A4 (enExample)
JP (2) JP2019530878A (enExample)
CN (2) CN109451744B (enExample)
AU (2) AU2017289600A1 (enExample)
CA (1) CA3024724A1 (enExample)
WO (1) WO2018004806A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109451744B (zh) * 2016-06-26 2022-08-05 斯坦福大学托管董事会 用于危重患者的死亡预后的生物标志物
WO2018140256A1 (en) * 2017-01-17 2018-08-02 Duke University Gene expression signatures useful to predict or diagnose sepsis and methods of using the same
EP3759235B1 (en) * 2018-02-27 2025-02-19 The Board Of Trustees Of The Leland Stanford Junior University Classifier for identification of robust sepsis subtypes
CA3133639A1 (en) * 2019-03-22 2020-10-01 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
JP2022530323A (ja) * 2019-04-28 2022-06-29 ビスビュー メディカル,インコーポレイテッド デジタル検出能力および無線接続性を有する分子診断デバイス
BR112022008068A2 (pt) * 2019-10-28 2022-07-12 Hoffmann La Roche Métodos para auxiliar na avaliação de risco de um paciente com suspeita de sepse e método implementado por computador para a avaliação de um paciente com suspeita de sepse
JP2023525489A (ja) * 2020-04-29 2023-06-16 インフラマティックス インコーポレイテッド ウイルス感染症を有する対象の死亡率リスクの決定
WO2022066963A1 (en) * 2020-09-25 2022-03-31 The Board Of Trustees Of The Leland Stanford Junior University Method for determining a virally-infected subject's risk of developing severe symptoms
CN114606308A (zh) * 2022-01-26 2022-06-10 江门市中心医院 脓毒症ards的预后与治疗标志物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245615A (en) 1991-06-06 1993-09-14 International Business Machines Corporation Diagnostic system and interface for a personal computer
NZ333718A (en) 1996-07-12 2000-10-27 First Opinion Corp Computerized medical diagnostic system utilizing list-based processing
MXPA05005072A (es) * 2002-11-12 2005-07-22 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
CN101208602A (zh) * 2005-04-15 2008-06-25 贝克顿迪金森公司 脓毒症的诊断
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
ATE472611T1 (de) * 2005-11-25 2010-07-15 Trinity College Dublin Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
EP2388594A1 (en) * 2010-05-17 2011-11-23 Roche Diagnostics GmbH GDF-15 based means and methods for survival and recovery prediction in acute inflammation
US20110312521A1 (en) * 2010-06-17 2011-12-22 Baylor Research Institute Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
US20120034214A1 (en) * 2010-07-22 2012-02-09 Isis Innovation Limited Methods and kits for determining the prognosis of pulmonary sarcoidosis
CN103403549B (zh) * 2011-01-11 2015-11-25 美迪恩斯生命科技株式会社 败血症的预后的预测方法
CA2827894A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
WO2013040099A2 (en) * 2011-09-12 2013-03-21 Langley Raymond Sepsis prognosis biomarkers
WO2014201516A2 (en) * 2013-06-20 2014-12-24 Immunexpress Pty Ltd Biomarker identification
WO2015135071A1 (en) * 2014-03-14 2015-09-17 Hancock Robert E W Diagnostic for sepsis
CN109451744B (zh) * 2016-06-26 2022-08-05 斯坦福大学托管董事会 用于危重患者的死亡预后的生物标志物

Similar Documents

Publication Publication Date Title
JP2019530878A5 (enExample)
TWI580788B (zh) 用於檢測川崎病的方法及套組
JP2018514189A5 (enExample)
ES2993025T3 (en) Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases
US20140094381A1 (en) Predictive Biomarkers for Response to Exercise
AU2019275457A1 (en) Circulating RNA signatures specific to preeclampsia
CN109295204B (zh) 诊断冠心病的外周血单个核细胞环状RNAs及相关应用
CA3166628A1 (en) Method for predicting the likelihood of ectopic pregnancy (ep), viable intrauterine pregnancy (viup), or non-viable intrauterine pregnancy (nviup).
WO2013179672A1 (ja) 子宮内膜症の判定方法
CN108026585B (zh) 多基因检测
RU2287158C1 (ru) Способ прогнозирования развития гипертонической болезни по генетическим факторам риска
CN102839172A (zh) HIV感染疾病进展分子标志物miR-503
CN107043770B (zh) 一组结核病相关的外周血淋巴细胞miRNA及其应用
RU2620561C1 (ru) Способ диагностики псориаза
Ju et al. Plasma cell‐free DNA analysis for COVID‐19 and beyond
Kasaras Future diagnostic of Sepsis: Biomarker miRSeps-5 manual vs robotic extraction and optimization of miRNA detection by Two-Tailed RT-qPCR technology
WO2021191485A1 (es) Biomarcadores para predecir la respuesta de un sujeto a una terapia con bcg, métodos y usos basados en los mismos
TWI626314B (zh) 評估罹患大腸直腸癌風險的方法
JP2015133919A (ja) 筋萎縮性側索硬化症のバイオマーカー
CN102839173B (zh) HIV感染疾病进展分子标志物miR-200c
Cazalis et al. Whole blood ratio of CDK1/CX3CR1 mRNA expression combined to lactate refines the prediction of ICU mortality in septic patients in the Sepsis-3 era: a proof-of-concept study
CN107619868B (zh) 胶质瘤预后标志物Circ3:129880309|129880559的应用
Tessier et al. Multiparametric profiling of plasma cell-free nucleic acids in nonagenarians and centenarians highlights age-related differences associated with longevity
CN107604074B (zh) 胶质瘤预后标志物circ15:101235082|101235577及应用
RU2649774C1 (ru) Способ прогнозирования исхода острой ишемии миокарда